Skip to main content

Video-Only Noninferior to In-Person Therapy After Thumb Carpometacarpal Arthroplasty

Medically reviewed by Carmen Pope, BPharm. Last updated on May 2, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 2, 2024 -- For upper-extremity function after thumb carpometacarpal (CMC) arthroplasty, video-only therapy (VOT) is noninferior to in-person therapy (IPT), according to a study published in the April 17 issue of the Journal of Bone & Joint Surgery.

Patrick C. Barrett, M.D., from the Virginia Tech Carilion School of Medicine in Roanoke, and colleagues performed a single-site, prospective, randomized controlled trial involving 50 female and eight male patients undergoing primary thumb CMC arthroplasty without an implant. The Patient-Reported Outcomes Measurement Information System (PROMIS) Upper Extremity (UE) score was the primary outcome measure. Patients in the VOT group were provided with three videos of home exercises to perform, while those in the control group received standardized IPT with a hand therapist.

Overall, 58 participants were included in the analysis at the 12-week time point and 54 were included at the one-year time point. The researchers found that for the PROMIS UE score, VOT was noninferior to IPT at 12 weeks and one year postoperatively, with a difference of mean improvement of 1.5 and 2.2, respectively, which were both below the minimal clinically important difference of 4.1. On average, the VOT group potentially saved 201.3 miles in travel.

"This trial yields evidence that a more patient-driven approach with provision of videos is an acceptable alternative to traditional IPT after thumb CMC arthroplasty and has the added benefit of reducing the potential travel burden for patients," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

High Level of Approval Observed for Polygenic Embryo Screening

FRIDAY, May 17, 2024 -- There is a high level of approval for use of polygenic embryo screening, according to a study published online May 14 in JAMA Network Open. Rémy A...

AI Chatbots Can Generate Quality, Empathetic, Readable Responses

FRIDAY, May 17, 2024 -- For patient questions about cancer, artificial intelligence (AI) chatbots can generate quality, empathetic, and readable responses, according to a study...

Slight Decline Seen in U.S. Drug Overdose Deaths

THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.